Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06871085 · ClinicalTrials.gov registry record · NA

Novel Sock Design on Ankle and Postural Stability

A NA study of Ankle Stability and Postural Stability, sponsored by University of Central Florida.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06871085: Recruiting NA study of Ankle Stability and Postural Stability, sponsored by University of Central Florida.

NCT06871085 is a NA study of Ankle Stability and Postural Stability that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06871085, a NA study of Ankle Stability and Postural Stability, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study uses a prospective cohort study design using a convenience sample to explore the sock's impact on various aspects of ankle function and overall stability. A secondary objective is measuring subjective changes in reported confidence levels in performing balance and stability exercises with and without sock

Primary Outcome

Grip strength will be measured using a hand dynamometer. Participants will sit in a chair with no armrests, feet flat on the floor, and squeeze the dynamometer with each hand while their forearm is positioned in a neutral position. Two trials will be conducted per hand, alternating hands with a 1-minute rest between each trial. The average of the two trials will be recorded. This assessment will take about 5 minutes.

Interventions

  • DEVICE Stability Sock

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-03
Est. Completion 2026-02-02
Phase NA
University of Central Florida

91 total trials

What NCT06871085 shows while recruiting

NCT06871085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Ankle Stability appearing as the primary indexed condition, and to 1 intervention - of which Stability Sock is the first listed.

NCT06871085 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06871085 about?

NCT06871085 is a clinical study titled "Novel Sock Design on Ankle and Postural Stability". This study uses a prospective cohort study design using a convenience sample to explore the sock's impact on various aspects of ankle function and overall stability. A secondary objective is measuring subjective changes in reported confidence levels in performing balance and stability exercises with...

What is the current status of trial NCT06871085?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-03. Estimated completion is 2026-02-02.

What conditions does trial NCT06871085 study?

This clinical trial studies the following conditions: Ankle Stability, Postural Stability.

What interventions are being tested in trial NCT06871085?

The interventions under investigation include: Stability Sock (DEVICE).

Who is sponsoring clinical trial NCT06871085?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06871085 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06871085's enrollment target sits among peer trials

30 1594th of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06871085, the US trial registry maintained by the National Library of Medicine. NCT06871085 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.